Long-term Cardiovascular Outcomes After mRNA Vaccination: A Multicenter Cohort Study

Long-term Cardiovascular Outcomes After mRNA Vaccination: A Multicenter Cohort Study

Eleanor Thompson*

Research Article2024DOIPeer Reviewed

Abstract

A multicenter prospective cohort study of 284,000 adults aged 18-75 followed over 24 months post-vaccination. We report all-cause cardiovascular event rates stratified by age, sex, and pre-existing conditions. No elevated risk of major adverse cardiovascular events was observed compared to matched unvaccinated controls (HR 0.94, 95% CI 0.88-1.01). Sub-group analysis confirms safety across high-risk comorbidity profiles.

Publication Information

AcceptedMarch 15, 2024

Author Information

Eleanor Thompson Corresponding Author
Affiliation: University of Oxford Medical School
KeywordsmRNA vaccine, cardiovascular outcomes, cohort study, safety monitoring, post-marketing surveillance

Additional Information

Views8
This paper is not open access. Please contact the corresponding author to request the full text.